Therefore, CNN2 is considered an important protein related to HCC, with potential uses as a biomarker for the serological diagnosis of HCC, early risk prediction of HCC metastasis, and as a reference for optimizing HCC treatment regimens and improving patient survival rates. The gene discussed is CNN2; the disease is hepatocellular carcinoma.